Overexpression of CD44 variants 6 and 7 in human endometrial cancer

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 185-189

  Katsura, Masumi ^a   Furumoto, Hiroyuki ^a   Nishimura, Masato ^a   Kamada, Masaharu ^a   Aono, Toshihiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CD44 variants; Endometrial cancer; Endometrium; Immunohistochemistry; Reverse transcription polymerase chain reaction

Indexed keywords

HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER INVASION; ENDOMETRIUM CANCER; EPITHELIUM CELL; EXON; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032213888     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5169     Document Type: Article

References (25)

1. Zaino R J, Kurman R, Herbold D, Gliedman J, Bundy B N, Voet R, Advani H. The significance of squamous differentiation in endometrial carcinoma: Data from a Gynecologic Oncology Group study. Cancer. 68:1991;2293-2302.
2. Jalkanen S, Bargatze R F, Toyos J, Butcher E C. Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol. 105:1987;983-990.
3. Heider K H, Hofmann M, Hors E, Berg F, Ponta H, Herrlich P, Pals S T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol. 120:1993;227-233.
4. Fox S B, Fawcett J, Jackson D G, Collins I, Gatter K C, Harris A L, Gearing A, Simmons D L. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res. 54:1994;4539-4546.
5. Gunthert U. CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol. 184:1993;47-63.
6. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
7. Koopman G, Heider K H, Horst E, Adolf G R, Berg F, Ponta H, Herrlich P, Pals S T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 177:1993;897-904.
8. Ristamaki R, Joensuu H, Soderstrom K O, Jalkanen S. CD44v6 expression in non-Hodgkin's lymphoma: An association with low histological grade and poor prognosis. J Pathol. 176:1995;259-267.
9. Kaufmann M, Heider K H, Sinn H P, Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival [see comments]. Lancet. 345:1995;615-619.
10. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrancois D, Theillet C. CD44 expression patterns in breast and colon tumors: A PCR-based study of splice variants. Int J Cancer. 64:1995;347-354.
11. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H, Furukawa K. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol. 14:1996;1122-1127.
12. Yamaguchi A, Saito M, Gio T, Iida A, Takeuchi K, Hirose K, Nakagawara G, Urano T, Furukawa K, Shiku H. Expression of CD44 variant exons 8-10 in gastric cancer. Jpn J Cancer Res. 86:1995;1166-1171.
13. Dammrich J, Vollmers H P, Heider K H, Muller H H. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading. J Mol Med. 73:1995;395-401.
14. Iida N, Bourguignon L Y. New CD44 splice variants associated with human breast cancers. J Cell Physiol. 162:1995;127-183.
15. Kallakury B V, Yang F, Figge J, Smith K E, Kausik S J, Tacy N J, Fisher H A, Kaufman R, Figge H, Ross J S. Decreased levels of CD44 protein and mRNA in prostate carcinoma: Correlation with tumor grade and ploidy. Cancer. 78:1996;1461-1469.
16. Nagabhushan M, Pretlow T G, Guo Y J, Amini S B, Pretlow T P, Sy M S. Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol. 106:1996;647-651.
17. Herold M C, Seiter S, Born A I, Patzelt E, Schupp M, Zoller J, Bosch F X, Zoller M. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol. 179:1996;66-73.
18. Wielenga V J, Heider K H, Offerhaus G J, Adolf G R, Berg F, Ponta H, Herrlich P, Pals S T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:1993;4754-4756.
19. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A. Expression of CD44 in normal human versus tumor endometrial tissues: Possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 54:1994;3922-3928.
20. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H. Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol. 57:1995;383-387.
21. Yokozaki H, Ito R, Nakayama H, Kuniyasu H, Taniyama K, Tahara E. Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett. 83:1994;229-234.
22. Imazeki F, Yokosuka O, Yamaguchi T, Ohto M, Isono K, Omata M. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology. 110:1996;362-368.
23. Yoshida K, Sugino T, Bolodeoku J, Warren B F, Goodison S, Woodman A, Toge T, Tahara E, Tarin D. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene. J Clin Pathol. 49:1996;300-305.
24. Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, Breitenecker G. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer. 31:1995;1706-1709.
25. Dall P, Heider K H, Sinn H P, Skroch A P, Adolf G, Kaufmann M, Herrlich P, Ponta H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer. 60:1991;471-477.